(Q88611062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

title

Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

inferred from title

author name string

Praveen Kumar Conjeevaram Selvakumar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Mohammad Nasser Kabbany

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Naim Alkhouri

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

1 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

315-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

Steatohepatitis in obese children: a cause of chronic liver dysfunction

26 March 2020

cites work

1 reference

12 December 2020

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

1 reference

12 December 2020

Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children

1 reference

12 December 2020

Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited

1 reference

12 December 2020

Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC).

1 reference

12 December 2020

Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

1 reference

12 December 2020

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

1 reference

12 December 2020

Vitamin E treatment in pediatric obesity-related liver disease: a randomized study

1 reference

12 December 2020

A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.

1 reference

12 December 2020

Stearoyl-CoA desaturase as a new drug target for obesity treatment.

1 reference

12 December 2020

Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents

1 reference

12 December 2020

The role of stearoyl-CoA desaturase in the control of metabolism

1 reference

12 December 2020

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice

1 reference

12 December 2020

Prevalence of fatty liver in children and adolescents.

1 reference

12 December 2020

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

12 December 2020

Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease.

1 reference

12 December 2020

Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis

1 reference

12 December 2020

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

1 reference

12 December 2020

Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.

1 reference

12 December 2020

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial

1 reference

12 December 2020

Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease

1 reference

12 December 2020

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

1 reference

12 December 2020

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.

1 reference

12 December 2020

Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils

1 reference

12 December 2020

Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents

1 reference

12 December 2020

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

12 December 2020

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

1 reference

12 December 2020

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

1 reference

12 December 2020

Advances in pediatric nonalcoholic fatty liver disease

1 reference

12 December 2020

A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents.

1 reference

12 December 2020

FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats

1 reference

12 December 2020

Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease

1 reference

12 December 2020

Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?

1 reference

12 December 2020

Interactions between obesity and obstructive sleep apnea: implications for treatment

1 reference

12 December 2020

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

12 December 2020

Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease

1 reference

12 December 2020

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

1 reference

12 December 2020

Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients

1 reference

12 December 2020

Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

1 reference

12 December 2020

Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease

1 reference

12 December 2020

Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study

1 reference

12 December 2020

Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease.

1 reference

12 December 2020

Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

1 reference

12 December 2020

Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease

1 reference

12 December 2020

Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease

1 reference

12 December 2020

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

1 reference

12 December 2020

Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children

1 reference

12 December 2020

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

1 reference

12 December 2020

Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial.

1 reference

12 December 2020

Childhood obesity and obstructive sleep apnea

1 reference

12 December 2020

Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease

1 reference

12 December 2020

A randomized trial of sugar-sweetened beverages and adolescent body weight

1 reference

12 December 2020

A trial of sugar-free or sugar-sweetened beverages and body weight in children

1 reference

12 December 2020

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis

1 reference

12 December 2020

Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010.

1 reference

12 December 2020

Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery

1 reference

12 December 2020

Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.

1 reference

12 December 2020

Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children.

1 reference

12 December 2020

Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis

1 reference

12 December 2020

Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease.

1 reference

12 December 2020

A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD.

1 reference

12 December 2020

Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children.

1 reference

12 December 2020

Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease

1 reference

12 December 2020

Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver

1 reference

12 December 2020

Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease

1 reference

12 December 2020

Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease

1 reference

12 December 2020

The Gordian Knot of dysbiosis, obesity and NAFLD.

1 reference

12 December 2020

Extrahepatic complications of nonalcoholic fatty liver disease

1 reference

12 December 2020

Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?

1 reference

12 December 2020

The I148M Variant of PNPLA3 Reduces the Response to Docosahexaenoic Acid in Children with Non-Alcoholic Fatty Liver Disease

1 reference

12 December 2020

Early left ventricular abnormality/dysfunction in obese children affected by NAFLD

1 reference

12 December 2020

Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance

1 reference

12 December 2020

Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents

1 reference

12 December 2020

Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease

1 reference

12 December 2020

Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis

1 reference

12 December 2020

The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial

1 reference

12 December 2020

Role of toll-like receptors in immune activation and tolerance in the liver

1 reference

12 December 2020

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

1 reference

12 December 2020

A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease

1 reference

12 December 2020

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

1 reference

12 December 2020

Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease

1 reference

12 December 2020

Obeticholic acid for the treatment of fatty liver disease—NASH no more?

1 reference

12 December 2020

Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

1 reference

12 December 2020

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

1 reference

12 December 2020

The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease

1 reference

12 December 2020

Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement

1 reference

12 December 2020

Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease

1 reference

12 December 2020

Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial

1 reference

12 December 2020

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

1 reference

12 December 2020

Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients

1 reference

12 December 2020

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.

1 reference

12 December 2020

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.

1 reference

12 December 2020

Liver transplantation for nonalcoholic steatohepatitis in young patients

1 reference

12 December 2020

Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study

1 reference

12 December 2020

The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis

1 reference

12 December 2020

Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents

1 reference

12 December 2020

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

1 reference

12 December 2020

Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice

1 reference

12 December 2020

Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

1 reference

12 December 2020

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

1 reference

12 December 2020

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

1 reference

12 December 2020

Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design

1 reference

12 December 2020

Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.

1 reference

12 December 2020

Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children

1 reference

12 December 2020

Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment

1 reference

12 December 2020

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

1 reference

12 December 2020

Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.

1 reference

12 December 2020

In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores

1 reference

12 December 2020

The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis

1 reference

12 December 2020

Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study

1 reference

12 December 2020

The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice

1 reference

12 December 2020

Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data

1 reference

12 December 2020

Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents

1 reference

12 December 2020

Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications

1 reference

12 December 2020

Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease

1 reference

12 December 2020

Prevalence of Obesity and Severe Obesity in US Children, 1999-2016.

1 reference

12 December 2020

To die or not to die: death signaling in nonalcoholic fatty liver disease.

1 reference

12 December 2020

10.1007/S40272-018-0292-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29740791%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference